Australian scientists are about to undertake a three year clinical trial of new treatments for schizophrenia.

Following promising early results, researchers are using a cancer and osteoperosis drug, in an effort to find an early detection treatment, that can stave off this serious neurological condition.

Professor Cindy Shannon Weickert (pronounced why-kart) is heading a joint initiative of the Schizophrenia Research Institute, the University of New South Wales and the Prince of Wales Medical Research Foundation.

She discussed the latest research with 2ser’s Cale Bain.